diabetes

Hua Medicine’s Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

indie 10 10 月

11 minutes

SHANGHAI, CHINA, Oct 10, 2022 […]

Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022

indie 7 6 月

6 minutes

SHANGHAI, CHINA, Jun 7, 2022 & […]

CUHK Professor Elaine Chow Receives “2022 Women’s Interprofessional Network of the American Diabetes Association Abstract Award” for Outstanding Research and Care in Diabetes

indie 5 6 月

2 minutes

HONG KONG, Jun 5, 2022 – […]

Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment

ruth 25 3 月

6 minutes

Tokyo and Salt Lake City, Indi […]

Hua Medicine Announces 2021 Annual Results

indie 17 3 月

8 minutes

SHANGHAI, CHINA, Mar 17, 2022 […]

Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin

indie 26 9 月

6 minutes

SHANGHAI, Sep 26, 2021 – […]

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China – First Glucokinase Activator (GKA) Globally

indie 23 4 月

7 minutes

SHANGHAI, CHINA, Apr 23, 2021 […]

Hua Medicine Successfully Completes Its Registration Phase III Trials; Announces 52-Week Results for DAWN (HMM0302), Dorzagliatin’s Phase III Combination with Metformin Trial

indie 18 12 月

12 minutes

SHANGHAI, CHINA, Dec 18, 2020 […]

Brawijaya University develops the GAD65 Rapid Test Diabetes Screening Kit

pandora 26 11 月

2 minutes

Malang, East Java, Indonesia, […]

Brawijaya University develops GAD65 Rapid Test Diabetes Screening Kit

indie 26 11 月

2 minutes

Malang, East Java, Indonesia, […]

Copyright © 2020 ASEANPR.Com All rights reserved.